Clinical site monitoring in human subjects, baltimore, MD (diclofenac study)
Ended Awarded Last action
- Contract number
- 75F40119F19012
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $353
Award facts
- Opportunity
-
- FDASOL1185780 Solicitation number
- Contract value 100% obligated
- $352.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21250, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,797 | |
| Original award | $4,150 |
Quick answers
Who was awarded contract 75F40119F19012?
75F40119F19012 was awarded to The Emmes Company, LLC by Food and Drug Administration (Department of Health and Human Services) on July 23, 2019.
How much is contract 75F40119F19012 worth?
The government has obligated $353 on 75F40119F19012.
Is contract 75F40119F19012 an order under another contract?
Yes. 75F40119F19012 is a delivery order under HHSF223201710031I, an indefinite delivery contract.
Was contract 75F40119F19012 competed?
The extent of competition for 75F40119F19012 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award